News

A study of more than 100 patients found that immunotherapy can cure a rare type of cancer in various tumor sites without ...
Recent research conducted by scientists in Ireland has revealed the significant role of lipid-rich fluid in the abdomen, ...
First part of a 2-part interview with Stephen Strickland, MD, MSCI, director of leukemia research for Sarah Cannon Research Institute. Strickland recently presented data from a phase 1 trial of ...
NEW YORK - A Ludwig Cancer Research study has identified a key mechanism by which advanced ovarian cancers suppress ...
New research has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body’s immune response in advanced ovarian cancer.
New research led by scientists in Ireland has uncovered how a fat-rich fluid found in the abdomen of ovarian cancer patients ...
New research has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body's immune response in advanced ovarian cancer. The findings offer new ...
Lipid receptor SR-B1 identified as a potential immunotherapy target to boost NK cell antitumor response in advanced ovarian ...
A Ludwig Cancer Research study has identified a key mechanism by which advanced ovarian cancers suppress anti-tumor immune ...
Researchers from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) and local biotechnology company Intra-ImmuSG ...
A recent study published in Engineering has shed new light on the mechanisms underlying the metastasis of head and neck squamous cell carcinoma (HNSCC).